Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 351

    1.

    Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.

    Muller A, Talon D, Potier A, Belle E, Cappelier G, Bertrand X.

    Crit Care. 2005 Jun;9(3):R246-50. Epub 2005 Mar 31.PMID: 15987397 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?

    Wertheim HF, Vos MC.

    Crit Care. 2005 Jun;9(3):257-8. Epub 2005 May 5.PMID: 15987417 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.

    Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, Dejoseph MA, Hospenthal DR.

    Antimicrob Agents Chemother. 2007 Oct;51(10):3591-8. Epub 2007 Aug 6.PMID: 17682105 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients.

    Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M.

    Infect Control Hosp Epidemiol. 2007 Oct;28(10):1155-61. Epub 2007 Aug 1.PMID: 17828692 [PubMed - indexed for MEDLINE]Related articles

    5.

    [The influence of the use of mupirocin nasal ointment on the incidence of endogenous MRSA infections in an intensive care unit]

    Hiramatsu N, Hashimoto S, Fujita N, Kageyama K, Ashida H, Kimura A, Kobayashi A, Tanaka Y.

    Masui. 2000 Aug;49(8):867-71. Japanese. PMID: 10998878 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.

    Wertheim HF, Vos MC, Ott A, Voss A, Kluytmans JA, Vandenbroucke-Grauls CM, Meester MH, van Keulen PH, Verbrugh HA.

    Ann Intern Med. 2004 Mar 16;140(6):419-25.PMID: 15023707 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.

    Dupeyron C, Campillo B, Richardet JP, Soussy CJ.

    J Hosp Infect. 2006 Aug;63(4):385-92. Epub 2006 Jun 12.PMID: 16772100 [PubMed - indexed for MEDLINE]Related articles

    8.

    Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.

    Sandri AM, Dalarosa MG, Ruschel de Alcantara L, da Silva Elias L, Zavascki AP.

    Infect Control Hosp Epidemiol. 2006 Feb;27(2):185-7. Epub 2006 Feb 8.PMID: 16465636 [PubMed - indexed for MEDLINE]Related articles

    9.

    A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.

    Dupeyron C, Campillo B, Bordes M, Faubert E, Richardet JP, Mangeney N.

    J Hosp Infect. 2002 Dec;52(4):281-7.PMID: 12473473 [PubMed - indexed for MEDLINE]Related articles

    10.

    Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.

    Hitomi S, Kubota M, Mori N, Baba S, Yano H, Okuzumi K, Kimura S.

    J Hosp Infect. 2000 Oct;46(2):123-9.PMID: 11049705 [PubMed - indexed for MEDLINE]Related articles

    11.

    Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.

    Oztoprak N, Cevik MA, Akinci E, Korkmaz M, Erbay A, Eren SS, Balaban N, Bodur H.

    Am J Infect Control. 2006 Feb;34(1):1-5.PMID: 16443085 [PubMed - indexed for MEDLINE]Related articles

    12.

    Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward.

    Mayall B, Martin R, Keenan AM, Irving L, Leeson P, Lamb K.

    J Hosp Infect. 1996 Apr;32(4):257-66.PMID: 8744510 [PubMed - indexed for MEDLINE]Related articles

    13.

    Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: efficacy of mupirocin ointment.

    Talon D, Rouget C, Cailleaux V, Bailly P, Thouverez M, Barale F, Michel-Briand Y.

    J Hosp Infect. 1995 May;30(1):39-49.PMID: 7665881 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection.

    Mangini E, Segal-Maurer S, Burns J, Avicolli A, Urban C, Mariano N, Grenner L, Rosenberg C, Rahal JJ.

    Infect Control Hosp Epidemiol. 2007 Nov;28(11):1261-6. Epub 2007 Sep 18.PMID: 17926277 [PubMed - indexed for MEDLINE]Related articles

    15.

    Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.

    Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, King P, Peterson LR.

    Ann Intern Med. 2008 Mar 18;148(6):409-18.PMID: 18347349 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.

    Miller MA, Dascal A, Portnoy J, Mendelson J.

    Infect Control Hosp Epidemiol. 1996 Dec;17(12):811-3.PMID: 8985769 [PubMed - indexed for MEDLINE]Related articles

    17.

    Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery.

    Mastoraki A, Kriaras I, Douka E, Mastoraki S, Stravopodis G, Geroulanos S.

    Interact Cardiovasc Thorac Surg. 2008 May;7(3):452-6. Epub 2008 Mar 17.PMID: 18346978 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus.

    Bertino JS Jr.

    Am J Health Syst Pharm. 1997 Oct 1;54(19):2185-91. Review.PMID: 9331438 [PubMed - indexed for MEDLINE]Related articles

    19.

    Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey.

    Troché G, Joly LM, Guibert M, Zazzo JF.

    Infect Control Hosp Epidemiol. 2005 Feb;26(2):161-5.PMID: 15756887 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduction in gram-positive pneumonia and antibiotic consumption following the use of a SDD protocol including nasal and oral mupirocin.

    Nardi G, Di Silvestre AD, De Monte A, Massarutti D, Proietti A, Grazia Troncon M, Lesa L, Zussino M.

    Eur J Emerg Med. 2001 Sep;8(3):203-14.PMID: 11587466 [PubMed - indexed for MEDLINE]Related articles